Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June
The Multi-stakeholder Platform Advisory Group (MSP Advisory Group) forms part of the ACT EU multi-stakeholder platform (ACT EU MSP), which aims to provide regulators and stakeholders with a platform to exchange views on clinical trials. The MSP brings the views from stakeholders into the ACT EU initiative through the work of the MSP Advisory Group, the organisation of ACT EU multi-stakeholder events and stakeholder consultations.
The MSP Advisory Group (MSP AG) is composed of representatives from key stakeholder groups. Its members provide:
- Strategic advice on the ACT EU workplan, helping identify stakeholder priorities.
- Operational input for ACT EU initiatives, including expert recommendations and engagement methodologies.
The next MSP AG meeting takes place on 26 June.
Agenda, pre-reads, and presentations are already available for visitors to explore on the following links
https://accelerating-clinical-trials.europa.eu/our-work/multi-stakeholder-platform_en